ClinicalTrials.Veeva

Menu

Role of Pancreatic Triglyceride Content in Beta-cell Function

The University of Texas System (UT) logo

The University of Texas System (UT)

Status

Completed

Conditions

Obesity
Type 2 Diabetes

Treatments

Other: No intervention planned.

Study type

Observational

Funder types

Other
NIH

Identifiers

NCT00602953
1K23RR02447001
042007-021

Details and patient eligibility

About

The study evaluates if fat accumulates in the pancreas in individuals at risk of developing obesity-related diabetes. It also evaluates if the amount of fat in the pancreas can predict the residual functional capacity of the pancreas (insulin secretion).

Enrollment

101 patients

Sex

All

Ages

21 to 99 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • adults without prior history of pancreatic disease (other than diabetes)

Exclusion criteria

  • use of unapproved medications
  • contraindications to the MRI procedure
  • contraindications to frequent blood draws
  • pregnancy
  • use of more than 2 alcoholic drinks/day

Trial design

101 participants in 5 patient groups

Healthy volunteers
Description:
Normal weight and normal glucose tolerance.
Treatment:
Other: No intervention planned.
Pre-diabetes
Description:
Impaired fasting glucose of impaired glucose tolerance.
Treatment:
Other: No intervention planned.
Overweight
Description:
Overweight or obese volunteers, but with normal fasting and postprandial glucose levels.
Treatment:
Other: No intervention planned.
Type 2 diabetes
Description:
Patients with type 2 diabetes.
Treatment:
Other: No intervention planned.
Type 1 diabetes
Description:
Patients with type 1 diabetes.
Treatment:
Other: No intervention planned.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems